Matches in Wikidata for { <http://www.wikidata.org/entity/Q80195293> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q80195293 description "article scientifique publié en 2007" @default.
- Q80195293 description "artículu científicu espublizáu en mayu de 2007" @default.
- Q80195293 description "scientific article published on 01 May 2007" @default.
- Q80195293 description "wetenschappelijk artikel" @default.
- Q80195293 description "наукова стаття, опублікована в травні 2007" @default.
- Q80195293 name "Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation" @default.
- Q80195293 name "Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation" @default.
- Q80195293 type Item @default.
- Q80195293 label "Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation" @default.
- Q80195293 label "Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation" @default.
- Q80195293 prefLabel "Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation" @default.
- Q80195293 prefLabel "Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation" @default.
- Q80195293 P1433 Q80195293-93F2E702-314B-45AE-87F8-D639EFDC1C4D @default.
- Q80195293 P1476 Q80195293-C48507FC-B7F8-44A8-A8A6-10477C438476 @default.
- Q80195293 P2093 Q80195293-2A1C9F70-8459-46C1-A615-26180EAC0432 @default.
- Q80195293 P2093 Q80195293-393DDE45-CBF3-4945-8CD0-B8F3D781DE78 @default.
- Q80195293 P2093 Q80195293-6380260E-0389-47CA-8441-E9C585BBDA84 @default.
- Q80195293 P2093 Q80195293-6AC5AC8B-F97C-4999-8149-60BC481BC898 @default.
- Q80195293 P2093 Q80195293-764DC935-C968-4A48-A740-18FAF1277B9F @default.
- Q80195293 P2093 Q80195293-92D073F4-EF1F-432A-A426-C4063BFD078A @default.
- Q80195293 P2093 Q80195293-D22BBA44-6EBC-46AC-9907-2B873F8A8E0E @default.
- Q80195293 P304 Q80195293-B5EA51F2-39D2-4F5D-95BE-419DB22E9845 @default.
- Q80195293 P31 Q80195293-68E5C4E6-9A25-4E01-89C8-18D15F445EF2 @default.
- Q80195293 P356 Q80195293-4CC2A68C-46EF-4A76-AC82-65D611AFE531 @default.
- Q80195293 P433 Q80195293-45A0DD4A-52A0-436E-87C2-4105342CC883 @default.
- Q80195293 P478 Q80195293-6517B891-780D-4E42-BAE0-775786BA5C75 @default.
- Q80195293 P577 Q80195293-1BBC5D04-D613-4072-B3DE-27189347AB3A @default.
- Q80195293 P698 Q80195293-029A5395-BE16-48EF-82D2-17617CB8E66C @default.
- Q80195293 P921 Q80195293-423FBF49-C78F-49D5-BBA7-E08ABB511755 @default.
- Q80195293 P921 Q80195293-4CA3C447-A973-49EC-9978-8BA14438D065 @default.
- Q80195293 P356 BLOOD-2006-12-061135 @default.
- Q80195293 P698 17449802 @default.
- Q80195293 P1433 Q885070 @default.
- Q80195293 P1476 "Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation" @default.
- Q80195293 P2093 "Anna Seegers" @default.
- Q80195293 P2093 "Felicitas Henneke" @default.
- Q80195293 P2093 "Guntram Buesche" @default.
- Q80195293 P2093 "Hans Heinrich Kreipe" @default.
- Q80195293 P2093 "Kais Hussein" @default.
- Q80195293 P2093 "Michael Flasshove" @default.
- Q80195293 P2093 "Oliver Bock" @default.
- Q80195293 P304 "4106-4107" @default.
- Q80195293 P31 Q13442814 @default.
- Q80195293 P356 "10.1182/BLOOD-2006-12-061135" @default.
- Q80195293 P433 "9" @default.
- Q80195293 P478 "109" @default.
- Q80195293 P577 "2007-05-01T00:00:00Z" @default.
- Q80195293 P698 "17449802" @default.
- Q80195293 P921 Q1752571 @default.
- Q80195293 P921 Q177094 @default.